mTOR and Beclin1: Two key autophagy-related molecules and their roles in myocardial ischemia/reperfusion injury.
Autophagy is the general term of lysosomal degradation of substances in cells, which is considered the key to maintaining the normal structure and function of the heart. It also has a correlation with several heart diseases, in particular, myocardial ischemia/reperfusion (I/R) injury. At the stage of myocardial ischemia, autophagy degrades nonfunctional cytoplasmic proteins providing the critical nutrients for the critical life activities, thereby suppressing cell apoptosis and necrosis. However, autophagy is likely to affect the heart negatively in the reperfusion stage. Mammalian target of rapamycin (mTOR) and Beclin1 are two vital autophagy-related molecules in myocardial I/R injury playing significant roles in different stages. In the ischemia stage, mTOR plays its roles through AMPK/mTOR and phosphoinositide 3-kinase/Akt/mTOR pathway, whereas Beclin1 plays its roles through its upregulation in the reperfusion stage. A possible interaction between mTOR and Beclin1 has been reported recently, and further studies need to be done to find the underlying interaction between the two molecules in myocardial I/R injury.
['Shi|Binhao|B|0000-0002-2439-5962', 'Ma|Mengqing|M|', 'Zheng|Yitian|Y|0000-0003-4438-845X', 'Pan|Yanyan|Y|', 'Lin|Xianhe|X|']
D000818:Animals D001343:Autophagy D000071186:Beclin-1 D006801:Humans D017202:Myocardial Ischemia D015427:Reperfusion Injury D058570:TOR Serine-Threonine Kinases
mTOR Beclin1 myocardial ischemia/reperfusion injury autophagy